Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study(legacy) | 340 |
| Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study(legacy) | 149 |
Total Visits per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study | 1 | 8 | 2 | 7 | 9 | 3 | 6 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| Australia | 122 |
| United States | 98 |
| China | 47 |
| France | 15 |
| Netherlands | 9 |
| Vietnam | 6 |
| Germany | 3 |
| Hong Kong SAR China | 2 |
| Argentina | 1 |
| United Kingdom | 1 |
Top City Views
| Views | |
|---|---|
| Kaleen | 71 |
| Ashburn | 31 |
| Beijing | 24 |
| Fairfield | 16 |
| Rotterdam | 8 |
| Hanoi | 6 |
| Boardman | 4 |
| Seattle | 3 |
| Brisbane | 2 |
| Cambridge | 2 |